Acorda Therapeutics

$8.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 2:40 PM UTC today

Why Robinhood?

You can buy or sell ACOR and other stocks, options, and ETFs commission-free!

About ACOR

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, and GGF2 (Cimaglermin alfa). The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY. The listed name for ACOR is Acorda Therapeutics, Inc. Common Stock.

CEO

Ronald Cohen

Employees

344

Headquarters

Ardsley, New York

Founded

1995

Market Cap

63.45M

Price-Earnings Ratio

1.43

Dividend Yield

—

Average Volume

4.70M

High Today

$8.25

Low Today

$7.95

Open Price

$8.25

Volume

68.40K

52 Week High

$15.30

52 Week Low

$2.53

Collections

ACOR Earnings

-$1.06

-$0.71

-$0.35

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 11, After Hours